Posted by Michael Wonder on 16 Feb 2021
Medicines Australia statement on TGA’s provisional approval of AstraZeneca’s COVID-19 vaccine
16 February 2021 - Medicines Australia welcomes the TGA’s decision granting provisional approval of the AstraZeneca/Oxford University COVID-19 vaccine, marking the second COVID-19 vaccine to receive regulatory approval in Australia.
This landmark decision is a testament to the swift action, hard work, and unprecedented collaboration between the industry, Government, and scientific community to address the pandemic.
